Latest Content

Researchers aim to better understand the perspectives of providers amid ongoing transformations.

The White House and the American Academy of Pediatrics leave pharmacists navigating 2 competing sets of vaccine guidance for the upcoming season.

This episode provides an introspective look at the people in pharmacy who are the hardest to lead toward a path of success.

A decades-long research effort in mRNA-produced licensed vaccines targets influenza, respiratory syncytial virus, cytomegalovirus, HIV, and cancer.

Separating medical and nonmedical products leads to a variety of better inventory decisions in community pharmacies.

Rae McMahan joins to provide key insights and updates on developing action between CVS Caremark, the FTC, and the rest of the pharmacy benefits industry.

When it comes to pain management, safer options such as acetaminophen have emerged as better choices for older adults.

Community pharmacies deliver personalized travel medicine, helping travelers leave protected and prepared.

Researchers aimed to better understand the prominence of vaccine failures and breakthrough infections of pediatric pneumoccoal immunization.

From their originally intended purposes to the growing indications showing promise in development, GLP-1 and GIP receptor agonists have evolved rapidly.

Community pharmacists deliver travel vaccine clinics, navigate entry rules, and update routine shots with new guidance on polio, measles, and chikungunya.

Despite significant progress made in the US opioid epidemic, systemic change is necessary to move pain management forward across health care.

Data on excess deaths in high-income countries show the male mortality disadvantage during COVID-19 is concentrated in the pandemic's earliest phase.

Counseling, team-based care, and tailored pharmacy interventions remain among the most effective tools against medication nonadherence in the United States.

The approval gives pharmacists a new, nonegg-based seasonal influenza option for adults 50 and older ahead of the 2026-2027 flu season.

Empathy amongst patients’ most trusted health care providers can translate to better outcomes and health care delivery.

Oveporexton, an oral orexin receptor 2 agonist, is the first medicine to restore orexin signaling rather than manage symptoms of the rare sleep disorder.

Following multiple exits in this role throughout President Trump’s second term, the new director’s tenure is reported to be permanent going forward.

This medication is the first FDA-approved OTC innovation in the cold and flu category in 14 years.

Episode 13 assesses the evolution of MASH, how it’s managed by pharmacists, and how it provides another avenue for improving cardiometabolic disease.

A study finds treated diabetes prevalence climbs steadily for 5 years after antipsychotic start, even with brief exposure.

Community pharmacists use medication therapy management and point-of-care testing for improved hemoglobin A1C, BP, and lipid assessment as well as adherence.

In part 2 of our conversation with Duane Jones, BS Pharm, he moves from nonopioid alternatives to the new and multidisciplinary approaches toward post-operative pain protocols.

In a case study based in a community pharmacy, researchers assess the dosage regimen of an older polymedicated patient to improve adherence and pharmacotherapy.

Results from a trial show injectable cabotegravir plus rilpivirine reduced viral rebound compared with daily oral therapy.

Community and independent pharmacists are beginning to test whether they can help fill the resulting gaps in medication management for older adults.

Researchers highlight the importance of vaccination for the risk reduction needed across the pediatric population.

With its popularity increasing on TikTok, melanotan II has been given monikers like ‘vacation peptide’ and ‘Barbie drug’ because of its effect on the skin.

Duane Jones, BS Pharm, shares some of his expert knowledge into why opioids were never the right pathway for patients experiencing acute or chronic pain.

What ties this issue together is not the size of the pharmacy involved but the resourcefulness required to keep serving patients.

Centuries of vaccine science saved more lives than any other intervention, and pharmacists matter now more than ever.